MEDIROM Healthcare Technologies
1 hedge funds and large institutions have $664K invested in MEDIROM Healthcare Technologies in 2021 Q2 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, 0 reducing their positions, and 3 closing their positions.
0.65% less ownership
Funds ownership: 2.05% → 1.4% (-0.65%)
75% less funds holding
Funds holding: 4 → 1 (-3)
100% less capital inflows, than outflows
Capital inflows: $0 | Capital outflows: $352K
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 3
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$218K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$113K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$21K |
MRM Hedge Fund Activity: Q2 2021 in Review
1 of the 5,769 institutional investors tracked by Wall St. Rank reported a position in MEDIROM Healthcare Technologies (MRM) for Q2 2021, worth a combined $664K — down 41% from $1.13M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of MRM and 0 opened new positions — a net loss of 3 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Citadel Advisors, exiting entirely with an estimated $218K sold.
- 1 institutional investor held MEDIROM Healthcare Technologies (MRM) as of Q2 2021, down from 4 in Q1 2021.
- Funds reported $664K of MEDIROM Healthcare Technologies stock for Q2 2021, down 41% quarter-over-quarter.
- 0 funds opened new MEDIROM Healthcare Technologies positions in Q2 2021 and 3 closed out, a net change of -3 holders.
- The largest MEDIROM Healthcare Technologies seller in Q2 2021 was Citadel Advisors, an estimated $218K sold.
Based on aggregated 13F filings for Q2 2021.